Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
Author:
Toledo-Romani María Eugenia, García-Carmenate Mayra, Verdecia-Sánchez Leslyhana, Pérez-Rodríguez Suzel, Rodriguez-González Meybis, Valenzuela-Silva Carmen, Paredes-Moreno Beatriz, Sanchez-Ramirez Belinda, González-Mugica Raúl, Hernández-Garcia Tays, Orosa-Vázquez Ivette, Díaz-Hernández Marianniz, Pérez-Guevara María Teresa, Enriquez-Puertas Juliet, Noa-Romero Enrique, Palenzuela-Diaz Ariel, Baro-Roman Gerardo, Mendoza-Hernández Ivis, Muñoz Yaima, Gómez-Maceo Yanet, Santos-Vega Bertha Leysi, Fernandez-Castillo SonsireORCID, Climent-Ruiz Yanet, Rodríguez-Noda Laura, Santana-Mederos Darielys, García-Vega Yanelda, Chen Guang-Wu, Doroud Delaram, Biglari Alireza, Boggiano-Ayo Tammy, Valdés-Balbín Yury, Rivera Daniel G., García-Rivera Dagmar, Vérez-Bencomo Vicente, Cubas-Curbelo Mailin, Rodríguez-Castillo Pedro Gabriel, Acevedo-Martínez Yosmel, Estoque-Cabrera Solangel, Ávila-Cabreja José Alejandro, Alfaro-Guzmán Ainadis, Zulueta-Pérez Lilian, Espino-Rojas Niurka Tamara, Medinas-Santos Gloria Margarita, Sarda-Rodriguez Ileana Luisa, Acosta-Martinez Mario Alejandro, Reyes-Matienzo Radamet, Coviella-Artime José Manuel, Morffi-Cinta Irania, Martínez-Pérez Marisel, Valera-Fernández Rodrigo, Garcés-Hechavarría Aniurka, Martínez-Bedoya Dayle, Garrido-Arteaga Raine, Cardoso-SanJorge Félix, Ramírez-Gonzalez Ubel, Quintero-Moreno Lauren, Ontivero-Pino Ivis, Martínez-Rivera Roselyn, Guillén-Obregón Berta, Lora-García Janet, Medina-Nápoles Maite, Espi-Ávila Jennifer, Fontanies-Fernández Marcos, Domínguez-Pentón Yeney Regla, Bergado-Baez Gretchen, Pi-Estopiñán Franciscary, Ojito-Magaz Eduardo, Rodríguez Misladys, Cruz-Sui Otto, García-Montero Majela, Dubed-Echevarría Marta, García-López Elena, Galano-Frutos Evelyn, Perez-Perez Alina, Morales-Ruano Susana, Brito-Pascual Idalmis, Amoroto Maité, Arteaga-García Amaylid
Reference37 articles.
1. COVID-19 Vaccine Tracker,2021 2. Vaccine shortages prompt changes to COVAX strategy;Usher;Lancet,2021 3. Molecular aspects concerning the use of the SARS-CoV-2 receptor binding domain as a target for preventive vaccines;Valdes-Balbin;ACS Cent. Sci.,2021 4. SARS-CoV-2 RBD-Tetanus toxoid conjugate vaccine induces a strong neutralizing immunity;Valdes-Balbin;ACS Chem. Biol.,2021 5. Safety and Immunogenicity of anti-SARS CoV-2 conjugate vaccine SOBERANA 02 in homologous or heterologous scheme: pooled analysis of Phase I and IIa clinical trials;Toledo-Romani;medRxiv,2021
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|